SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, SensiCardiac Mobi, assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. In contrast, Tool B, Us2.v2, automates the interpretation of echocardiograms to deliver comprehensive structured reports with measurements and disease detection. While both are FDA-cleared AI tools for cardiology decision support, they operate on distinct data types—acoustic signals versus cardiac imaging—making them complementary rather than direct substitutes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
SensiCardiac Mobi is designed for real-time auscultation, assisting physicians in differentiating heart murmurs by analyzing acoustic signals captured via a mobile application and compatible electronic stethoscope during the initial patient assessment. Us2.v2 integrates into post-acquisition echocardiogram workflows, automating the interpretation of echo images from any ultrasound manufacturer to deliver structured reports and disease detection, thereby streamlining the reporting phase.
SensiCardiac Mobi operates as a mobile application for data capture and display, complementing physician assessment, but the provided information does not specify direct integration capabilities with EHR systems for automated data transfer. Us2.v2 offers seamless integration with existing PACS, CVIS, or EMR systems, supporting both HL7 and DICOM SR for the automated transfer of complete structured echo reports, measurements, and clinical findings.
SensiCardiac Mobi's AI analyzes acoustic heart signals to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs to aid in the initial diagnosis of heart murmurs. Us2.v2's AI automates echocardiogram interpretation, detecting cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, providing guideline-adherent measurements and clinical findings in a structured report.
SensiCardiac Mobi involves using a mobile application with a compatible electronic stethoscope for data capture, suggesting a potentially straightforward learning curve for integrating heart sound analysis into physical exams. The time-to-value for SensiCardiac Mobi would be in aiding immediate diagnostic assessment of murmurs, while Us2.v2 can significantly reduce echocardiogram reporting time by up to 70% and increase daily scan throughput, indicating a rapid time-to-value once integrated.
SensiCardiac Mobi acquires and records acoustic heart signals and identifies suspected murmurs, but the provided information does not detail specific audit-trail features for tracking AI-generated findings or physician modifications. Us2.v2 features guideline-adherent and explainable AI with transparent visual overlays and editable outputs, allowing for review and modification of the AI's interpretations within the complete structured echo report, and offers structured QA with an audit log for core lab solutions.
The provided information for SensiCardiac Mobi does not detail customer references or multi-site rollout considerations. Us2.v2 is deployed across hospitals and research centers in multiple countries and is designed to integrate with existing PACS, CVIS, or EMR systems, suggesting considerations for multi-site rollouts are addressed through its flexible deployment and integration options.